Phase 3 Results of the ULTIMATE I & II Global Studies: Ublituximab Versus Teriflunomide in Relapsing Multiple Sclerosis

Drug Category : Array
Conference Category : Array
Lead Author : Steinman L, et al.
Published Date : 14/10/2021
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2021/10/Steinman-ORAL-ECTRIMS-2021-PH3-ULTIMATE-I-II-10.13.21.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top